Status:
COMPLETED
PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease
Lead Sponsor:
Fatima Jinnah Medical University
Conditions:
Regenerative Medicine
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
An experimental study will be conducted at Iffat Anwar medical complex conducted to evaluate the effectiveness of PRP and stem Cell therapy in the treatment of PD. After the initial cognitive and labo...
Detailed Description
Parkinson's disease the second most common neurological disease worldwide is a progressive disorder that affects movement and can cause tremors, stiffness, and difficulty with coordination and balance...
Eligibility Criteria
Inclusion
- The diagnosis of clinically established PD for at least 1-3 years,
- Both genders aged between 30 to 50 years
- On stable therapy (dopaminergic medication and/or deep brain stimulation parameters)
Exclusion
- Gout, congestive heart failure, renal failure
- Uncontrolled atrial fibrillation, stroke, anaphylaxis, blood clotting problem,
- Clinical suspicion or diagnosis of atypical forms of parkinsonism or essential tremor
Key Trial Info
Start Date :
September 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06142981
Start Date
September 10 2019
End Date
December 15 2022
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
gull e Rukh
Lahore, Punjab Province, Pakistan, 54780